Literature DB >> 6632950

Liver fibrosis (cardiac cirrhosis) five years after modified Fontan operation for tricuspid atresia.

J H Lemmer, A G Coran, D M Behrendt, K P Heidelberger, A M Stern.   

Abstract

A 15-year-old girl was found to have severe liver fibrosis on liver biopsy at the time of cholecystectomy, 5 1/2 years following a modified Fontan procedure (right atrial-right ventricular conduit) for tricuspid atresia. Postoperative right atrial pressures were consistently elevated above 13 mm Hg and this, in part, may have been due to progressive mild conduit stenosis. Because of increasing symptoms, the patient underwent successful revision of the conduit at the age of 15 years. It is suggested that sustained systemic venous hypertension caused the striking morphologic changes in the liver and that this serious complication may significantly affect the long-term prognosis of patients surviving the Fontan procedure.

Entities:  

Mesh:

Year:  1983        PMID: 6632950

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  13 in total

1.  Functional deterioration of the liver by elevated inferior vena cava pressure: a proposed upper safety limit of pressure for maintaining liver viability in dogs.

Authors:  H Higashiyama; M Yamaguchi; K Kumada; H Sasaki; T Yamaguchi; K Ozawa
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

2.  Clinical profile of the adolescent/adult Fontan survivor.

Authors:  Nancy A Pike; Lorraine S Evangelista; Lynn V Doering; Deborah Koniak-Griffin; Alan B Lewis; John S Child
Journal:  Congenit Heart Dis       Date:  2011 Jan-Feb       Impact factor: 2.007

3.  Hepatic adenomatosis in a 7-year-old child treated earlier with a Fontan procedure.

Authors:  Kadir Babaoglu; Fatih Köksal Binnetoglu; Ayşen Aydoğan; Gürkan Altun; Yeşim Gürbüz; Nagihan Inan; Funda Corapçioğlu
Journal:  Pediatr Cardiol       Date:  2010-03-04       Impact factor: 1.655

4.  Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection.

Authors:  H B Ravn; V E Hjortdal; E V Stenbog; K Emmertsen; O Kromann; J Pedersen; K E Sorensen
Journal:  Heart       Date:  2001-01       Impact factor: 5.994

5.  A case of Fontan-related hepatocellular carcinoma successfully treated with proton beam therapy.

Authors:  Yuri Ogasawara; Tomomi Kogiso; Takaomi Sagawa; Kazuhisa Kodama; Makiko Taniai; Haruko Numajiri; Hideyuki Sakurai; Katsutoshi Tokushige
Journal:  Clin J Gastroenterol       Date:  2019-07-04

6.  Abnormalities in liver function and coagulation profile following the Fontan procedure.

Authors:  R C van Nieuwenhuizen; M Peters; L J Lubbers; M D Trip; J G Tijssen; B J Mulder
Journal:  Heart       Date:  1999-07       Impact factor: 5.994

7.  Transvenous hepatic biopsy in stable Fontan patients undergoing cardiac catheterization.

Authors:  William N Evans; Brody J Winn; Noel S Yumiaco; Alvaro Galindo; Abraham Rothman; Ruben J Acherman; Humberto Restrepo
Journal:  Pediatr Cardiol       Date:  2014-05-10       Impact factor: 1.655

8.  The Fontan pathway: What's down the road?

Authors:  Sachin Khambadkone
Journal:  Ann Pediatr Cardiol       Date:  2008-07

9.  Fontan Liver Disease: Review of an Emerging Epidemic and Management Options.

Authors:  Elisa Bradley; Benjamin Hendrickson; Curt Daniels
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-11

10.  Anesthetic management of laparoscopic pheochromocytoma excision in a patient with a Fontan circulation: a case report.

Authors:  Hyung-Chul Lee; Karam Nam; Ji-Hyun Lee; Yong-Hee Park; Hee-Soo Kim; Chong-Sung Kim; Jin-Tae Kim
Journal:  Korean J Anesthesiol       Date:  2014-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.